Structural deletions affecting Ebf1 and Ikzf1, two lymphoid transcription factors identified as frequent targets of second hit mutations in pediatric B-ALL [2, 5], suggest shared leukemogenic processes between human and murine HD-ALL. This evidence concerns the gene EBF1 and Huntington disease.